Brief: Cann Group Says Acquisition Of Zalm Therapeutics By Rua Bioscience Approved By Rua Shareholders
Jan 20 (Reuters) - Cann Group Ltd CAN.AX :
* ACQUISITION OF ZALM THERAPEUTICS BY RUA BIOSCIENCE LTD
APPROVED
BY RUA'S SHAREHOLDERS
Source text for Eikon: ID:nASX1JBTRm
Further company coverage: CAN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cann
See all newsBrief: Cann Group Posts Q1 Revenue A$3.45 Million
Brief: Cann Group Increases Private Credit Loan Facility By A$2 Million
Brief: Cann Group Says Mike Ryan To Assume Role Of Interim Exec Chair
Brief: Cann Group Anticipates FY2026 Revenue Of A$9.2-A$10 Million
Brief: Cann Group Posts Profit For Half-Year A$26.4 Million